Scilex Holding (SCLX) EBT (QoQ) (2020 - 2026)
Scilex Holding (SCLX) EBT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn |
| 10 | Scilex Holding | 48.31 Mn | -101.62 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.97% |
| Dec 31, 2025 | 82.12% |
| Sep 30, 2025 | -485.57% |
| Jun 30, 2025 | -68.82% |
| Mar 31, 2025 | -303.65% |
| Dec 31, 2024 | -47.24% |
| Sep 30, 2024 | 88.32% |
| Jun 30, 2024 | -54.17% |
| Mar 31, 2024 | -13.95% |
| Dec 31, 2023 | 39.79% |
| Sep 30, 2023 | -33.31% |
| Jun 30, 2023 | 13.31% |
| Mar 31, 2023 | -72.30% |
| Dec 31, 2022 | -183.03% |
| Sep 30, 2022 | 220.28% |
| Jun 30, 2022 | -95.47% |
| Mar 31, 2022 | 74.08% |
| Dec 31, 2021 | -12,425.08% |
| Sep 30, 2021 | -70.28% |
| Jun 30, 2021 | -13.46% |